IL33 and esophageal squamous cell carcinoma: During the occurrence and development of human esophageal squamous cell carcinoma (ESCC), the activation of ODC can increase the secretion of IL-33 in the tumor site, thereby promoting the polarization of macrophages to the anti-inflammatory M2 phenotype (144).